Coenzyme Q10 Improves Sperm Parameters, Oxidative Stress Markers and Sperm DNA Fragmentation in Infertile Patients with Idiopathic Oligoasthenozoospermia

다국어 초록 (Multilingual Abstract)

Purpose: Oxidative stress and sperm DNA fragmentation (SDF) are potential contributing factors for idiopathic male infertility.
Coenzyme Q10 (CoQ10) have been reported to be effective in the treatment of idiopathic male infertility, in general, owing to its antioxidant properties. Thus, the present study intends to investigate the effects of CoQ10 therapy on semen parameters, oxidative stress markers and SDF in infertile men, specifically with idiopathic oligoasthenozoospermia (OA).
Materials and Methods: In this case-control study, sixty-five infertile patients with idiopathic OA and forty fertile men (control) were included. All participants underwent semen analysis based on the World Health Organization guidelines (5th edition, 2010). Patients received CoQ10 at the dose of 200 mg/d orally for three months. Seminal plasma CoQ10, total antioxidant capacity (TAC), total reactive oxygen species (ROS), glutathione peroxidase (GPx), and SDF levels were measured in controls (baseline) and infertile patients pre- and post-CoQ10 treatment.
Results: CoQ10 treatment for three months significantly improved sperm concentration (p<0.05), progressive motility (p<0.05), total motility (p<0.01), seminal fluid CoQ10 concentration (p<0.001), TAC (p<0.001), and GPx (p<0.001) levels in infertile men with OA. Further, ROS level (p<0.05) and SDF percentage (p<0.001) were reduced in OA patients as compared to the baseline. CoQ10 levels also correlated positively with sperm concentration (r=0.48, p=0.01) and total motility (r=0.59, p=0.003) while a negative correlation was recorded between SDF and sperm motility (r=-0.54, p=0.006).
Conclusions: CoQ10 supplementation for three months could improve semen parameters, oxidative stress markers and reduce SDF in infertile men with idiopathic OA.

참고문헌 (Reference)

1 World Health Organization, "WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction" Cambridge University Press 1999

2 World Health Organization, "WHO laboratory manual for the examination and processing of human semen. 5th ed"

3 Lewin A, "The effect of coenzyme Q10 on sperm motility and function" 18 (18): S213-S219, 1997

4 Zegers-Hochschild F, "The International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary on ART terminology, 2009" 24 : 2683-2687, 2009

5 Carrell DT, "Sperm DNA fragmentation is increased in couples with unexplained recurrent pregnancy loss" 49 : 49-55, 2003

6 Agarwal A, "Role of reactive oxygen species in the pathophysiology of human reproduction" 79 : 829-843, 2003

7 Alahmar AT, "Role of oxidative stress in male infertility : an updated review" 12 : 4-18, 2019

8 Venkatesh S, "Reactive oxygen species measurement in neat and washed semen : comparative analysis and its significance in male infertility assessment" 283 : 121-126, 2011

9 Darbandi M, "Reactive oxygen species and male reproductive hormones" 16 : 87-, 2018

10 Bhagavan HN, "Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations" 7 (7): S78-S88, 2007

11 Dutta S, "Oxidative stress and sperm function : a systematic review on evaluation and management" 17 : 87-97, 2019

12 Sikka SC., "Oxidative stress and role of antioxidants in normal and abnormal sperm function" 1 : e78-e86, 1996

13 Ilacqua A, "Lifestyle and fertility : the influence of stress and quality of life on male fertility" 16 : 115-, 2018

14 Rutstein SO, "Infecundity, infertility, and childless ness in developing countries" ORC Macro and World Health Organization 2004

15 Panerselvam M, "Genetics of male infertility: a case-based guide for clinicians" Elsevier 2020

16 Tadros NN, "Empiric medical therapy with hormonal agents for idiopathic male infertility" 33 : 194-198, 2017

17 Safarinejad MR, "Efficacy of coenzyme Q10 on semen parameters, sperm function and reproductive hormones in infertile men" 182 : 237-248, 2009

18 Zaazaa A, "Effect of varicocelectomy and/or mast cells stabilizer on sperm DNA fragmentation in infertile patients with varicocele" 6 : 146-150, 2018

19 Li K, "Determination of coenzyme Q10 in human seminal plasma by high-performance liquid chromatography and its clinical application" 20 : 1082-1086, 2006

20 Ozmen B, "DNA damage of human spermatozoa in assisted reproduction:origins, diagnosis, impacts and safety" 14 : 384-395, 2007

21 Bhagavan HN, "Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics" 40 : 445-453, 2006

22 Mancini A, "Coenzyme Q10 concentrations in normal and pathological human seminal fluid" 15 : 591-594, 1994

23 Balercia G, "Coenzyme Q10 and male infertility" 32 : 626-632, 2009

24 Balercia G, "Coenzyme Q(10) supplementation in infertile men with idiopathic asthenozoospermia: an open, uncontrolled pilot study" 81 : 93-98, 2004

25 Ghanbarzadeh S, "CoQ10and L-carnitine attenuate the effect of high LDL and oxidized LDL on spermatogenesis in male rats" 64 : 510-515, 2014

26 Eroglu M, "Blood serum and seminal plasma selenium, total antioxidant capacity and coenzyme Q10 levels in relation to semen parameters in men with idiopathic infertility" 159 : 46-51, 2014

27 Ahmadi S, "Antioxidant supplements and semen parameters : an evidence based review" 14 : 729-736, 2016

28 Kobori Y, "Antioxidant cosupplementation therapy with vitamin C, vitamin E, and coenzyme Q10 in patients with oligoasthenozoospermia" 86 : 1-4, 2014

29 Agarwal A, "A unique view on male infertility around the globe" 13 : 37-, 2015

30 Panner Selvam MK, "A systematic review on sperm DNA fragmentation in male factor infertility : laboratory assessment" 16 : 65-76, 2018